Ziprasidone-related neuroleptic malignant syndrome in a patient with Parkinson's disease: A diagnostic challenge

Nicola Gray

doi:10.1002/hup.578

Ziprasidone-related neuroleptic malignant syndrome in a patient with Parkinson's disease: A diagnostic challenge

Nicola Gray

Department of Psychiatry and Behavioral Health

Research output: Contribution to journal › Article › peer-review

26 Scopus citations

Abstract

A case of neuroleptic malignant syndrome (NMS) in a patient with Parkinson's disease (PD) is presented. The syndrome was precipitated by the atypical antipsychotic, ziprasidone. The challenge of recognizing NMS in a patient with underlying parkinsonian symptoms, where prominent symptom overlap can occur, is discussed.

Original language	English (US)
Pages (from-to)	205-207
Number of pages	3
Journal	Human Psychopharmacology
Volume	19
Issue number	3
DOIs	https://doi.org/10.1002/hup.578
State	Published - Apr 1 2004

All Science Journal Classification (ASJC) codes

Neurology
Clinical Neurology
Psychiatry and Mental health
Pharmacology (medical)

Access to Document

10.1002/hup.578

Fingerprint Dive into the research topics of 'Ziprasidone-related neuroleptic malignant syndrome in a patient with Parkinson's disease: A diagnostic challenge'. Together they form a unique fingerprint.

Cite this

@article{03b375fe577d4fdba5be3751176a3353,

title = "Ziprasidone-related neuroleptic malignant syndrome in a patient with Parkinson's disease: A diagnostic challenge",

abstract = "A case of neuroleptic malignant syndrome (NMS) in a patient with Parkinson's disease (PD) is presented. The syndrome was precipitated by the atypical antipsychotic, ziprasidone. The challenge of recognizing NMS in a patient with underlying parkinsonian symptoms, where prominent symptom overlap can occur, is discussed.",

author = "Nicola Gray",

year = "2004",

month = apr,

day = "1",

doi = "10.1002/hup.578",

language = "English (US)",

volume = "19",

pages = "205--207",

journal = "Human Psychopharmacology",

issn = "0885-6222",

publisher = "John Wiley and Sons Ltd",

number = "3",

}

TY - JOUR

T1 - Ziprasidone-related neuroleptic malignant syndrome in a patient with Parkinson's disease

T2 - A diagnostic challenge

AU - Gray, Nicola

PY - 2004/4/1

Y1 - 2004/4/1

N2 - A case of neuroleptic malignant syndrome (NMS) in a patient with Parkinson's disease (PD) is presented. The syndrome was precipitated by the atypical antipsychotic, ziprasidone. The challenge of recognizing NMS in a patient with underlying parkinsonian symptoms, where prominent symptom overlap can occur, is discussed.

AB - A case of neuroleptic malignant syndrome (NMS) in a patient with Parkinson's disease (PD) is presented. The syndrome was precipitated by the atypical antipsychotic, ziprasidone. The challenge of recognizing NMS in a patient with underlying parkinsonian symptoms, where prominent symptom overlap can occur, is discussed.

UR - http://www.scopus.com/inward/record.url?scp=1942488288&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1942488288&partnerID=8YFLogxK

U2 - 10.1002/hup.578

DO - 10.1002/hup.578

M3 - Article

C2 - 15079855

AN - SCOPUS:1942488288

VL - 19

SP - 205

EP - 207

JO - Human Psychopharmacology

JF - Human Psychopharmacology

SN - 0885-6222

IS - 3

ER -

Ziprasidone-related neuroleptic malignant syndrome in a patient with Parkinson's disease: A diagnostic challenge

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this